Stratification of flare intensity identifies placebo responders in a treatment efficacy trial of patients with osteoarthritis
Authors:
- 1 July 2001
- journal article
- clinical trial
- Published by Wiley in Arthritis & Rheumatism
- Vol. 44 (7) , 1599-1607
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: Results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hipArthritis & Rheumatism, 2000
- Treatment of Osteoarthritis With Celecoxib, a Cyclooxygenase-2 Inhibitor: A Randomized Controlled TrialMayo Clinic Proceedings, 1999
- Comparison of the efficacy and safety of oxaprozin and nabumetone in the treatment of patients with osteoarthritis of the kneeClinical Therapeutics, 1995